The effectiveness of corticosteroids in antihistamine-resistant chronic urticaria (CU) is widely accepted although large studies on their use in this disease are lacking.
Objective: To describe the baseline characteristics of the first 1539 German AWARE patients with H1-antihistamine-refractory CSU.
Objective: To describe disease burden, quality of life (QoL), and treatment patterns of patients with H1 antihistamine refractory CSU in Germany.
P: For the symptomatic relief of insect bites and stings and nettle rash. GSL: For the symptomatic relief of insect bites and stings and nettle stings.
The study is designed to explore the mode of action for omalizumab therapy in patients with chronic idiopathic urticaria.
There is a lack of large, randomized, double-blind studies that address antihistamine updosing for chronic spontaneous urticaria (CSU). The objective of this systematic review is to explore and...
Genentech/Roche has announced that the FDA has accepted and filed the company's supplemental Biologics License Application (sBLA) for subcutaneous use...
We aimed to explore the efficacy of hypertonic saline nasal irritation (HSNI) for improving nasal symptoms and quality of life, and for decreasing oral antihistamine consumption in children with allergic rhinitis (AR).
H(1)-antihistamines are first line treatment of chronic urticaria, but many patients do not get satisfactory relief with recommended doses. European guidelines recommend increased antihistamine doses of up to 4-fold.
Symptomatic treatment of allergic conditions e.g.:- Urticaria, pruritus, allergic rashes, stings and insect bites.